Jeffrey Lawson, MD, PhD
Jeffrey H. Lawson, M.D., Ph.D. is Humacyte’s President and Chief Executive Officer. He is a physician-scientist and vascular surgeon who has been involved in the development of Humacyte’s vascular technologies since the company’s founding in 2004.
Prior to Dr. Lawson’s appointment as President and Chief Executive Officer in 2018, he served as Humacyte’s Chief Medical Officer since 2015, where he was responsible for overseeing the clinical development of Humacyte’s vascular technologies as the company initiated Phase III clinical trials for dialysis access and expanded clinical programs in vascular repair and trauma.
Prior to joining Humacyte, Dr. Lawson served in leadership roles at Duke University Medical Center, including Professor of Surgery and Pathology, Vice Chair for Research in Surgery, and Director of Clinical Trials for the Department of Surgery.
Dr. Lawson has had a lifelong interest in the field of blood coagulation and vascular biology and has continuously studied these areas both scientifically and clinically in his laboratory at Duke University Medical Center. As a recognized leader in the field of vascular translational technology, Dr. Lawson’s research laboratory has received grants from the American Heart Association, National Institutes of Health, the Department of Defense and various biotechnology companies.
Dr. Lawson currently serves on the Board of Directors for the Kidney Health Initiative (KHI), is an American Board of Surgery certified Vascular Surgeon, a Fellow of the American Surgical Association and the current President of the Vascular Access Society of the Americas (VASA). He is also the co-author of over 120 journal articles on the topics of hemostasis, tissue engineering and vascular surgery and lectures on these topics both nationally and internationally.
Dr. Lawson earned his medical degree and his Ph.D. in Cell and Molecular Biology from the University of Vermont and completed his residency in General and Thoracic Surgery and his fellowship in Vascular Surgery at Duke University Medical Center.